If you backed PowerCell Sweden for its growing marine orders and OEM partnerships, the result has been painful. Holding PowerCell Sweden over the past year would have meant a 43.3% loss, including dividends. The drop sits alongside fresh news of a SEK 27 million follow up marine order and a swing from SEK 22.413 million profit to a SEK 51.201 million loss in Q2. If you bought on 16 October 2025 expecting smoother earnings, which specific assumptions about OEM demand, margins or royalty stability now look most exposed?
Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.
PowerCell Sweden is not the only name tied to this theme. Zero in on 32 best rare earth metal stocks and compare how each one is priced.
The Two PowerCell Sweden Stories Investors Had To Weigh
The shares cost SEK34.04 at the start of the period, and anyone looking at PowerCell Sweden then was really choosing between two very different stories.
The bullish narrative put Fair Value at SEK40, 18% above the start price. It leaned on growing OEM partnerships and regulatory support, and assumed smoother earnings helped by expanding royalty streams and improving net margins from operational efficiency.
The bearish view pointed to a Fair Value of SEK30, 12% below the start price. It focused on slow hydrogen infrastructure rollout, high capital needs, and the risk that large, lumpy IP deals and concentrated partners could strain cash flow and margins.
What The Results Changed For PowerCell Sweden
The SEK27 million marine order extended PowerCell Sweden's role with GMI Group and supported the optimistic case around OEM demand and decarbonization projects. The reported results, however, told a different story. Revenue fell from SEK129.979 million in Q2 2025 to SEK36.992 million in Q2 2026, and the business moved from a SEK22.413 million profit to a SEK51.201 million loss. This shift provided support for a more cautious view of earnings quality.
The main lesson is to separate contract headlines from income quality. When a pitch leans on smoother earnings or royalties, it is important to track net income and net margin. In this case, net margin moved from 17.2% to a loss margin of 138.4%, which helps clarify whether any claimed stability is actually taking shape.
What You Are Really Paying For In PowerCell Sweden Today
PowerCell Sweden trades at SEK18.21 after a 43.3% loss over the past year. The selected Narrative argues that its Fair Value sits above the current price, anchored in a thesis around marine, data center and royalty projects rather than broad hydrogen enthusiasm.
The core question is whether project volatility eases as that pipeline turns into delivered systems. A buyer today needs to judge if marine, data center and Bosch related royalty income can grow enough to outweigh lumpy quarters and still support more resilient earnings.
"The main thing that has to go right is that PowerCell Sweden converts its growing marine and power generation project pipeline into delivered multi megawatt systems while keeping its asset light model and rightsized cost base intact as hydrogen demand remains uneven."
The price and this Narrative do not agree. → Uncover what this Narrative says PowerCell Sweden is actually worth
Find Your Own Contrarian Opportunity
This company's disappointment is already part of the story. Your next idea could come from looking where the price and the possibilities still seem far apart. Here are three companies priced below our estimates.
-
Company 1 - 43% below our estimate - targets higher income shoppers and tourists through new prime-location stores.
-
Company 2 - 36% below our estimate - combines an expanded product lineup with new technology access from a recent integration.
-
Company 3 - 20% below our estimate - shifts from export led refining toward an integrated model focused on retail outlets.
That is three of the list. See every one of the 186 undervalued companies on it →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include PCELL.ST .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
